Business Services Industry

Business Horizons

View more issues:

Articles in Jan-Feb, 1996 issue of Business Horizons

Toward global convergence - differences in culture, economics, values, disappear across the world
by William B. Werther
Gainsharing: a lemon or lemonade?
by Woodruff Imberman
Improving profitability through product triage
by Robert G. Docters
The stalled revolution: business education in Eastern Europe
by Dag R. Bennett
The Faculty-in-Residence program - Wake Forest University's Babcock School of Management
by Bernard L. Beatty
Transfer pricing by multinational marketers: risky business
by John P. Fraedrich
Challenges in managing technology in transnational multipartner networks
by John W. Medcof
Why make managers? - highly skilled employees need not be groomed for management
by Peter Meyer
Fear of the needle? The future of Hong Kong business
by H.L. Chan
Green issues - social and legal considerations for companies making products more environmentally safe
by J. Stephen Shi
Investing in India: strategies for tackling bureaucratic hurdles
by Sanjiv Kumar
Comparable worth: the Canadian legislation - implementation of pay equity laws in Canada
by Kenneth A. Kovach
Will the real socially responsible consumer please step forward? - marketing
by James A. Roberts

Most Recent Business Articles

Most Recent Business Publications

Most Popular Business Articles

Most Popular Business Publications

Your Work How to Conduct a Job Interview

How to Conduct a Job Interview

Got a key position to fill? Hiring good employees is the foundation of any successful business.
Your Industry Biogen Corners the Social-Media Market For Its Drugs

Biogen Corners the Social-Media Market For Its Drugs

On November 2, Biogen Idec updated the prescribing label for its blockbuster multiple sclerosis drug Tysabri (natalizumab) after consultation with the FDA. Aside from acknowledging that the risk of developing progressive multifocal leukoencephalopathy (PML), an often fatal brain infection, increases with longer duration of treatment, no other revisions concerning the risk of PML were required. The fact that this biologic remains a cornerstone treatment for adult patients with relapsing forms of MS -- only the second drug to ever return to U.S. pharmacy shelves after having been withdrawn -- speaks volumes to the growing influence of the worldwide web.
Your Money Lower Your Taxes: 10 Moves to Make Now

Lower Your Taxes: 10 Moves to Make Now

Don’t wait until December to look for ways to trim your 2009 taxes. That will be too late to take advantage of some key tax breaks that require a little time to implement. So start making these moves now — before it’s too late to claim the write-offs on your ’09 return.